{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T04:21:35Z","timestamp":1782879695890,"version":"3.54.5"},"reference-count":116,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.vaccine.2008.07.056","type":"journal-article","created":{"date-parts":[[2008,8,10]],"date-time":"2008-08-10T08:13:36Z","timestamp":1218356016000},"page":"6244-6257","source":"Crossref","is-referenced-by-count":49,"title":["Prophylactic HPV vaccines: New interventions for cancer control"],"prefix":"10.1016","volume":"26","author":[{"given":"Eliav","family":"Barr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Sings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.07.056_bib1","unstructured":"World Health Organization. State of the art of new vaccines: Research and Development: Initiative for Vaccine Research. Available at http:\/\/www.who.int\/vaccines-documents\/DocsPDF06\/814.pdf [accessed Feb 29, 2008]."},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2008.07.056_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000203877","article-title":"AIDS-related non-Hodgkins lymphomas: molecular genetics, viral infection and cytokine deregulation","volume":"95","author":"Gaidano","year":"1996","journal-title":"Acta Haematol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.056_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cld.2004.12.009","article-title":"Epidemiology of hepatocellular carcinoma","volume":"9","author":"Bosch","year":"2005","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.vaccine.2008.07.056_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.vaccine.2008.07.056_bib5","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.vaccine.2005.01.016","article-title":"Vaccination against human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"23","author":"Franco","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.056_bib6","first-page":"557","article-title":"Papillomavairus","author":"Bonnez","year":"2002","journal-title":"Clin Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.056_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.admecli.2004.03.001","article-title":"Human papillomavirus and cervical cytology in adolescents","volume":"15","author":"Kahn","year":"2004","journal-title":"Adolesc Med Clin"},{"issue":"6","key":"10.1016\/j.vaccine.2008.07.056_bib8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.056_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjc.6601024","article-title":"Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis","volume":"89","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2008.07.056_bib10","unstructured":"Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5 Version 2.0 IARC Press. Available at: www-depdb.iarc.fr\/globocan\/GLOBOCAN2002.HTM [accessed March 15, 2005]."},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2008.07.056_bib11","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"Chapter 2: the burden of HPV-related cancers","volume":"24","author":"Parkin","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.07.056_bib12","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/01.AOG.0000210268.57527.a1","article-title":"Trends in the incidence of invasive and in situ vulvar carcinoma","volume":"107","author":"Judson","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.07.056_bib13","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/01.AOG.0000187301.76283.7f","article-title":"Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women","volume":"106","author":"Jones","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.07.056_bib14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0029-7844(97)00298-6","article-title":"Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia","volume":"90","author":"Jones","year":"1997","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.07.056_bib15","first-page":"601","article-title":"The predominance of human papillomavirus type 16 in vulvar neoplasia","volume":"71","author":"Buscema","year":"1988","journal-title":"Obstet Gynecol"},{"issue":"5A","key":"10.1016\/j.vaccine.2008.07.056_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9343(97)00177-0","article-title":"Epidemiology of genital human papillomavirus infection","volume":"102","author":"Koutsky","year":"1997","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2008.07.056_bib17","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1471-0528.1996.tb09771.x","article-title":"Vulvar intraepithelial neoplasia: long term follow up of treated and untreated women","volume":"103","author":"Herod","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.07.056_bib18","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0029-7844(00)00949-2","article-title":"Spontaneous regression of vulvar intraepithelial neoplasia 2\u20133","volume":"96","author":"Jones","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2008.07.056_bib19","unstructured":"Winter-Roach B, Monaghan J, de Lopes A. Colposcopy of the vagina. EAGC Course Book on Colposcopy. Primed-X Press; 2004: p. 120\u20133."},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.056_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/gyno.2001.6401","article-title":"Clinical features and risk of recurrence among patients with vaginal intraepithelial neoplasia","volume":"83","author":"Dodge","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.07.056_bib21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00006250-198609000-00008","article-title":"Vaginal intraepithelial neoplasia\u2014biologic aspects and management","volume":"68","author":"Lenehan","year":"1986","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.07.056_bib22","first-page":"294","article-title":"Multifocal squamous neoplasia of the female genital-tract\u2014significance of human papillomavirus infection of the vagina after hysterectomy","volume":"70","author":"Schneider","year":"1987","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2008.07.056_bib23","unstructured":"American Society for Colposcopy and Cervical Pathology. ASCCP practice recommendations: practice management materials: the vagina. Available at www.asccp.org\/edu\/practice\/vagina\/neoplasia.shtml [accessed Feb 29, 2008]."},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.056_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/1097-0142(19910701)68:1<195::AID-CNCR2820680135>3.0.CO;2-L","article-title":"Natural history of vaginal intraepithelial neoplasia","volume":"68","author":"Aho","year":"1991","journal-title":"Cancer"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2008.07.056_bib25","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1086\/342109","article-title":"External genital warts: diagnosis, treatment and prevention","volume":"35","author":"Wiley","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2008.07.056_bib26","unstructured":"The American Society of Colon and Rectal Surgeons. Patient information, anal cancer. Available at http:\/\/ascrs affiniscape.com\/displaycommon cfm?an=1&subarticlenbr=2 [accessed Feb 28, 2008]."},{"key":"10.1016\/j.vaccine.2008.07.056_bib27","unstructured":"The Vaccine Development Team. The current status of development of prophylactic vaccines against human papillomavirus infection. Report of a technical meeting, Geneve, 16\u201316 February 1999. Available at http:\/\/www.who.int\/vaccines-documents\/DocsPDF99\/www9914.pdf World Health Organization [accessed Feb 13, 2008]."},{"issue":"19","key":"10.1016\/j.vaccine.2008.07.056_bib28","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199711063371904","article-title":"Sexually transmitted infection as a cause of anal cancer","volume":"337","author":"Frisch","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2008.07.056_bib29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.med.55.091902.103520","article-title":"Human papillomavirus vaccines and prevention of cervical cancer","volume":"55","author":"Jansen","year":"2004","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.vaccine.2008.07.056_bib30","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00001622-200009000-00013","article-title":"New technologies in cervical cancer precursor detection","volume":"12","author":"Soler","year":"2000","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.056_bib31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0889-8588(05)70163-5","article-title":"Epidemiology of genital human papillomavirus","volume":"13","author":"Tortolero-Luna","year":"1999","journal-title":"Hematol Oncol Clin North Am"},{"issue":"11","key":"10.1016\/j.vaccine.2008.07.056_bib32","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00007435-200111000-00006","article-title":"Condylomata acuminata (genital warts)\u2014patient demographics and treating physicians","volume":"28","author":"Fleischer","year":"2001","journal-title":"Sex Transm Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2008.07.056_bib33","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.olq.0000145851.76025.ad","article-title":"Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States","volume":"31","author":"Koshiol","year":"2004","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2008.07.056_bib34","unstructured":"Health Protection Agency. Focus on prevention: HIV and other sexually transmitted infections in the United Kingdom in 2003\u2014an update: November 2004. London, England United Kingdom; 2004."},{"issue":"5","key":"10.1016\/j.vaccine.2008.07.056_bib35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/427557","article-title":"Development and duration of human papillomavirus lesions, after initial infection","volume":"191","author":"Winer","year":"2005","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.07.056_bib36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1067\/mjd.2002.122198","article-title":"Penile lesions and human papillomavirus in male sexual partners of women with cervical intraepithelial neoplasia","volume":"47","author":"Bleeker","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.vaccine.2008.07.056_bib37","unstructured":"Centers for Disease Control and Prevention. HPV and men\u2014CDC fact sheet. Available at http:\/\/www.cdc.gov\/std\/hpv\/STDFact-HPV-and-men.htm [accessed Feb 13, 2008]."},{"issue":"3","key":"10.1016\/j.vaccine.2008.07.056_bib38","first-page":"753","article-title":"Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses","volume":"59","author":"Frisch","year":"1999","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.056_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0090-4295(93)90640-V","article-title":"Human papillomavirus infection and intraepithelial, in-situ, and invasive-carcinoma of penis","volume":"42","author":"Malek","year":"1993","journal-title":"Urology"},{"issue":"10","key":"10.1016\/j.vaccine.2008.07.056_bib40","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/jmv.20703","article-title":"The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand","volume":"78","author":"Senba","year":"2006","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.056_bib41","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/154405910708600202","article-title":"The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus","volume":"86","author":"Ragin","year":"2007","journal-title":"J Dental Res"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.056_bib42","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","article-title":"Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review","volume":"14","author":"Kreimer","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1016\/j.vaccine.2008.07.056_bib43","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2007.14.1713","article-title":"Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States","volume":"26","author":"Chaturvedi","year":"2008","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.07.056_bib44","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1002\/ijc.22177","article-title":"Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer","volume":"119","author":"Hammarstedt","year":"2006","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.vaccine.2008.07.056_bib45","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1542\/peds.2006-1555","article-title":"Recurrent respiratory papillomatosis in children: Masquerader of common respiratory diseases","volume":"118","author":"Zacharisen","year":"2006","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.056_bib46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hed.20491","article-title":"Juvenile recurrent respiratory papillomatosis: still a mystery disease with difficult management","volume":"29","author":"Stamataki","year":"2007","journal-title":"Head Neck-J Sci Specialt Head Neck"},{"key":"10.1016\/j.vaccine.2008.07.056_bib47","unstructured":"Genital HPV infection. Centers for Disease Control & Prevention. Available at: http:\/\/www.cdc.gov\/std\/HPV\/STDFact-HPV.htm [accessed Feb 15, 2008]."},{"key":"10.1016\/j.vaccine.2008.07.056_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1471-0528.2002.01053.x","article-title":"High incidence of cervical human papillomavirus infection in women during their first sexual relationship","volume":"109","author":"Collins","year":"2002","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.07.056_bib49","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/aje\/kwf180","article-title":"Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students","volume":"157","author":"Winer","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.07.056_bib50","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00007435-200211000-00018","article-title":"Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis","volume":"29","author":"Manhart","year":"2002","journal-title":"Sex Transm Dis"},{"issue":"23","key":"10.1016\/j.vaccine.2008.07.056_bib51","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/jnci\/djg107","article-title":"Human papillomavirus and oral cancer: the international agency for research on cancer multicenter study","volume":"95","author":"Herrero","year":"2003","journal-title":"J National Cancer Instit"},{"key":"10.1016\/j.vaccine.2008.07.056_bib52","first-page":"46","article-title":"Prevention of cervical cancer through papillomavirus vaccination","volume":"4","author":"Frazer","year":"2004","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.056_bib53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.OLQ.0000105327.40288.DB","article-title":"Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission","volume":"31","author":"Smith","year":"2004","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2008.07.056_bib54","first-page":"950","article-title":"Human papillomavirus DNA in fomites on objects used for the management of patients with genital human papillomavirus infections","volume":"74","author":"Ferenczy","year":"1989","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.07.056_bib55","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1086\/516515","article-title":"Papillomavirus is resistant to desiccation","volume":"176","author":"Roden","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.07.056_bib56","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0733-8635(01)00028-6","article-title":"Human papillomavirus: a review","volume":"20","author":"Brentjens","year":"2002","journal-title":"Dermatol Clin"},{"issue":"10","key":"10.1016\/j.vaccine.2008.07.056_bib57","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1001\/archpedi.158.10.966","article-title":"Adolescent and young adult women\u2019s misunderstanding of the term Pap smear","volume":"158","author":"Blake","year":"2004","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"10.1016\/j.vaccine.2008.07.056_bib58","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/j.1600-0412.2003.00086.x","article-title":"Eligibility and willingness of young Icelandic women to participate in a HPV vaccination trial","volume":"82","author":"Gudmundsdottir","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"10.1016\/j.vaccine.2008.07.056_bib59","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/her\/cyf022","article-title":"Human papillomavirus and the value of screening: young women\u2019s knowledge of cervical cancer","volume":"18","author":"Philips","year":"2003","journal-title":"Health Educ Res"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.056_bib60","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.bjc.6600686","article-title":"Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani. African-Caribbean and white British women in the UK","volume":"88","author":"McCaffery","year":"2003","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.vaccine.2008.07.056_bib61","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/sti.79.4.320","article-title":"Awareness of human papillomavirus among women attending a well woman clinic","volume":"79","author":"Waller","year":"2003","journal-title":"Sex Transm Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2008.07.056_bib62","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3322\/canjclin.54.5.248","article-title":"HPV communication: review of existing research and recommendations for patient education","volume":"54","author":"Anhang","year":"2004","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.056_bib63","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ajog.2004.01.042","article-title":"The health care costs of cervical human papillomavirus-related disease","volume":"191","author":"Insinga","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.056_bib64","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00043764-200301000-00007","article-title":"The health and productivity cost burden of the \u201ctop 10\u201d physical and mental health conditions affecting six large US employers in 1999","volume":"45","author":"Goetzel","year":"2003","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.vaccine.2008.07.056_bib65","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-04-0812","article-title":"Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer","volume":"14","author":"Clifford","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"10.1016\/j.vaccine.2008.07.056_bib66","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2165\/00019053-200523110-00004","article-title":"Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US\u2014analytic framework and review of the literature","volume":"23","author":"Insinga","year":"2005","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.056_bib67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1363\/3601104","article-title":"The estimated direct medical cost of sexually transmitted diseases among American youth, 2000","volume":"36","author":"Chesson","year":"2004","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.vaccine.2008.07.056_bib68","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/375074","article-title":"The health and economic burden of genital warts in a set of private health plans in the United States","volume":"36","author":"Insinga","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2008.07.056_bib69","first-page":"337","article-title":"Direct medical costs for surgical and medical treatment of condylomata acuminata","volume":"137","author":"Alam","year":"2001","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.07.056_bib70","first-page":"2335","article-title":"Management of genital warts","volume":"70","author":"Kodner","year":"2004","journal-title":"Am Fam Phys"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.056_bib71","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1086\/426867","article-title":"A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women","volume":"191","author":"Brown","year":"2005","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.07.056_bib72","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1586\/14760584.2.3.381","article-title":"Progress in prophylactic and therapeutic vaccines for human papillomavirus infection","volume":"2","author":"Stanley","year":"2003","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.056_bib73","first-page":"151","article-title":"Anti human papillomavirus vaccine: the checkmate to human papillomavirus?","volume":"25","author":"Moscarini","year":"2004","journal-title":"Eur J Gynaecol Oncol"},{"issue":"16","key":"10.1016\/j.vaccine.2008.07.056_bib74","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/0264-410X(95)00103-8","article-title":"Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation","volume":"13","author":"Jansen","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.056_bib75","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/viro.1996.0220","article-title":"Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization","volume":"219","author":"Kirnbauer","year":"1996","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.056_bib76","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/0042-6822(92)90463-Y","article-title":"Effective vaccination against papilloma development by immunization with L1 Or L2 structural protein of cottontail rabbit papillomavirus","volume":"187","author":"Lin","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.07.056_bib77","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1073\/pnas.92.25.11553","article-title":"Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas","volume":"92","author":"Suzich","year":"1995","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2008.07.056_bib78","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrmicro867","article-title":"Delivering on the promise: HPV vaccines and cervical cancer","volume":"2","author":"Schiller","year":"2004","journal-title":"Nat Rev"},{"issue":"8","key":"10.1016\/j.vaccine.2008.07.056_bib79","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1473-3099(03)00720-5","article-title":"Papillomavirus vaccines in clinical trials","volume":"3","author":"Galloway","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2008.07.056_bib80","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1586\/14760584.2.4.495","article-title":"Preventative and therapeutic vaccines for cervical cancer","volume":"2","author":"Roden","year":"2003","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2008.07.056_bib81","series-title":"Tumors of the cervix, vagina and vulva, third series, fascicle 4. Atlas of Tumor Pathology","author":"Kurman","year":"1992"},{"key":"10.1016\/j.vaccine.2008.07.056_bib82","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.vaccine.2004.07.046","article-title":"Efficacy and other milestones for human papillomavirus vaccine introduction","volume":"23","author":"Pagliusi","year":"2004","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.07.056_bib83","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"issue":"19","key":"10.1016\/j.vaccine.2008.07.056_bib84","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2008.07.056_bib85","doi-asserted-by":"crossref","unstructured":"The FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356(19):1915\u201327.","DOI":"10.1056\/NEJMoa061741"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.056_bib86","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.AOG.0000192397.41191.fb","article-title":"Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial","volume":"107","author":"Mao","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.07.056_bib87","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1097\/PAS.0b013e318058a544","article-title":"Longitudinal evaluation of interobserver and intraobserver agreement of cervical intraepithelial neoplasia diagnosis among an experienced panel of gynecologic pathologists","volume":"31","author":"Cai","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"16","key":"10.1016\/j.vaccine.2008.07.056_bib88","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.287.16.2120","article-title":"2001 consensus guidelines for the management of women with cervical cytological abnormalities","volume":"287","author":"Wright","year":"2002","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.vaccine.2008.07.056_bib89","first-page":"1866","article-title":"The 2001 ASCCP management guidelines for cervical cytology","volume":"70","author":"Ferris","year":"2004","journal-title":"Am Fam Phys"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.056_bib90","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jmv.20512","article-title":"Detection of specific human papillomavirus types in paraffin-embedded sections of cervical carcinomas","volume":"78","author":"Bryan","year":"2006","journal-title":"J Med Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2008.07.056_bib91","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1128\/CDLI.12.8.959-969.2005","article-title":"Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomavirus 6, 11, 16 and 18","volume":"12","author":"Dias","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.07.056_bib92","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1128\/JVI.64.11.5678-5681.1990","article-title":"Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11","volume":"64","author":"Christensen","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.07.056_bib93","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/viro.1996.0466","article-title":"Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies","volume":"223","author":"Christensen","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.07.056_bib94","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1994.1649","article-title":"Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes","volume":"205","author":"Christensen","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.07.056_bib95","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(07)60777-6","article-title":"Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16 and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three clinical trials","volume":"369","author":"Joura","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.07.056_bib96","doi-asserted-by":"crossref","unstructured":"The FUTURE II Study Group. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3 and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 2007; 369:1861\u20138.","DOI":"10.1016\/S0140-6736(07)60852-6"},{"key":"10.1016\/j.vaccine.2008.07.056_bib97","series-title":"Immunobiology: the immune system in health and disease","author":"Janeway","year":"2005"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.056_bib98","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00003081-200006000-00015","article-title":"Natural history of cervical neoplasia: defining progression and its consequence","volume":"43","author":"Pinto","year":"2000","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2008.07.056_bib99","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0140-6736(98)12490-X","article-title":"Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective study","volume":"354","author":"Nobbenhuis","year":"1999","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2008.07.056_bib100","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.vaccine.2005.09.002","article-title":"Immune responses to human papillomavirus","volume":"24","author":"Stanley","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.056_bib101","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1086\/521679","article-title":"Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine","volume":"196","author":"Giuliano","year":"2007","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2008.07.056_bib102","first-page":"877","article-title":"Time course of humoral and cell-mediated immune responses to human papillomavirus type 16 in infected women","volume":"9","author":"Nakagawa","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.07.056_bib103","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1586\/14760584.6.4.559","article-title":"Improving vaccines by incorporating immunological coadjuvants","volume":"6","author":"Fraser","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2008.07.056_bib104","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1016\/j.vaccine.2007.03.049","article-title":"Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6\/11\/16\/18 L1 virus-like-particle vaccine","volume":"25","author":"Olsson","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.056_bib105","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1016\/j.vaccine.2006.04.068","article-title":"Immunologic responses following administration of a vaccine targeting human papillomavirus types 6, 11, 16 and 18","volume":"24","author":"Villa","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.07.056_bib106","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1542\/peds.2006-0461","article-title":"Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women","volume":"118","author":"Block","year":"2006","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2008.07.056_bib107","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.inf.0000253970.29190.5a","article-title":"Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial","volume":"26","author":"Reisinger","year":"2007","journal-title":"Ped Infect Dis J"},{"issue":"11","key":"10.1016\/j.vaccine.2008.07.056_bib108","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","article-title":"High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6\/11\/16\/18 L1 virus-like particle vaccine through 5 years of follow-up","volume":"95","author":"Villa","year":"2006","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.056_bib109","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.57.1.7","article-title":"American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.vaccine.2008.07.056_bib110","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1086\/520654","article-title":"Quadrivalent human papillomavirus vaccine","volume":"45","author":"Barr","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2008.07.056_bib111","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/jnci\/92.6.464","article-title":"Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica","volume":"92","author":"Herrero","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.vaccine.2008.07.056_bib112","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/ijc.22241","article-title":"Variations in the age-specific curves of human papillomavirus prevalence in women worldwide","volume":"119","author":"Franceschi","year":"2006","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.vaccine.2008.07.056_bib113","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1086\/428779","article-title":"A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica","volume":"191","author":"Castle","year":"2005","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2008.07.056_bib114","first-page":"503","article-title":"Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada","volume":"163","author":"Sellors","year":"2000","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.056_bib115","first-page":"20","article-title":"The effect of aging on mucosal host defense","volume":"8","author":"Cunningham-Rundles","year":"2004","journal-title":"J Nutr Health Aging"},{"issue":"4","key":"10.1016\/j.vaccine.2008.07.056_bib116","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0891-5520(20)30624-3","article-title":"Human papillomaviruses","volume":"8","author":"McCance","year":"1994","journal-title":"Infect Dis Clin North Am"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0800950X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0800950X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T15:38:15Z","timestamp":1631633895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0800950X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":116,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0264410X0800950X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.07.056","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}